Clinical Trial Update: Study With Various Immunotherapy Treatments in Participants With Lung Cancer [Phase 2]

View source ↗

Summary

This clinical trial update describes a Phase 2 study of various immunotherapy treatments for advanced non-small cell lung cancer, sponsored by Gilead Sciences. …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Snippet

Sponsor: Gilead Sciences | Conditions: Advanced Non-Small Cell Lung Cancer | Phase 2 | Status: ACTIVE_NOT_RECRUITING